Cargando…

Antitumor Activity and Cellular Accumulation of a New Platinum Complex, (—)‐(R)‐2‐Aminomethylpyrrolidine(1,l‐cyclobutanedicarboxylato)platinum(II) Monohydrate, in Cisplatin‐sensitive and ‐resistant Murine P388 Leukemia Cells

We have examined the cytotoxicity and accumulation of (—)‐(U)‐2‐aminomethylpyrrolidine(1,l‐cyclobutanedicarboxylato)platinum(II) monohydrate (DWA2114R) in parent and cisplatin‐resistant mouse P388 leukemia cells (P388 and P388/DDP), in comparison with those of cisplatin (CDDP) and carboplatin (CBDCA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kamisango, Keiichi, Matsumoto, Tomoko, Akamatsu, Ken‐ichi, Morikawa, Kazumi, Tashiro, Tazuko, Koizumi, Kinya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1992
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918806/ https://www.ncbi.nlm.nih.gov/pubmed/1582895 http://dx.doi.org/10.1111/j.1349-7006.1992.tb00105.x

Ejemplares similares

Comparison of the antitumour effects and nephrotoxicity-inducing activities of two new platinum complexes, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato+ ++)-platinum (II) monohydrate, and its enantiomeric isomer.
por: Matsumoto, T., et al.
Publicado: (1991)

Potent antitumour activity of (-)-(R)-2-aminomethylpyrrolidine (1,1-cyclobutanedicarboxylato)platinum(II) monohydrate (DWA2114R) against advanced L1210 leukaemia in mice.
por: Akamatsu, K., et al.
Publicado: (1992)

Toxicological and Tumoricidal Evaluations of a New Platinum Complex, (–)‐(R)‐2‐Aminomethy lpyrrolidine (1,1‐cyclobutanedicarboxylato) platinum (II) Monohydrate, in Rats
por: Akamatsu, Ken‐ichi, et al.
Publicado: (1991)

Flow Cytometric Analyses of the Characteristics of Tumor Cells Treated with Two Platinum Compounds: 1,1‐Cyclobutanedicarboxylato(2‐aminomethylpyrrolidine)‐platinum(II) and Cisplatin
por: Inoue, Shoichi, et al.
Publicado: (1992)

Sequence‐dependent Termination of Mammalian DNA Polymerase Reaction by a New Platinum Compound, (–)‐(R)‐2‐Aminomethylpyrrolidine(1,1‐cyclobutane‐dicarboxylato)‐2‐platinum(II) Monohydrate
por: Iwata, Mitsumasa, et al.
Publicado: (1991)

Potentiation of cis‐Diammine(1, 1‐cyclobutanedicarboxylato)platinum(II) by Amphotericin B in BALB/c Nude Mice Bearing Human Ovarian Carcinoma Cells
por: Kojima, Masayoshi, et al.
Publicado: (1994)

A new anticancer platinum compound, (-)-(R)-2-aminomethyl-pyrrolidine(1,1-cyclobutanedicarboxylato) platinum(II): DNA interstrand crosslinking, repair and lethal effects in normal human, Fanconi's anaemia and xeroderma pigmentosum cells.
por: Fujiwara, Y., et al.
Publicado: (1993)

Platinum-containing compound platinum pyrithione is stronger and safer than cisplatin in cancer therapy
por: Zhao, Chong, et al.
Publicado: (2016)

Antitumor Trans Platinum Adducts of GMP and AMP
por: Liu, Yangzhong, et al.
Publicado: (2000)

Epigenetic and antitumor effects of platinum(IV)-octanoato conjugates
por: Novohradsky, Vojtech, et al.
Publicado: (2017)

Platinum and Palladium Complexes as Promising Sources for Antitumor Treatments
por: Czarnomysy, Robert, et al.
Publicado: (2021)

Binding Characteristics of (–)‐(R)‐2‐Aminomethylpyrrolidine(1,1‐cyclobutanedi‐carboxylato)‐2‐platinum(II) to DNA, RNA and Protein Molecules in HeLa Cells and Its Lethal Effect: Comparison with cis‐ and trans‐Diammmedichloroplatinums(II)
por: Akaboshi, Mitsuhiko, et al.
Publicado: (1994)

Platinum (II) Compounds With Antitumor Activity Studied by Molecular Mechanics
por: Trendafilova, Natasha, et al.
Publicado: (1998)

Stereochemical control of nucleosome targeting by platinum-intercalator antitumor agents
por: Chua, Eugene Y.D., et al.
Publicado: (2015)

The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents
por: Zhou, Jiabei, et al.
Publicado: (2020)

Long-term platinum retention after treatment with cisplatin and oxaliplatin
por: Brouwers, Elke EM, et al.
Publicado: (2008)

Cisplatin-Membrane Interactions and Their Influence on Platinum Complexes Activity and Toxicity
por: Martinho, Nuno, et al.
Publicado: (2019)

Cisplatin Protein Binding Partners and Their Relevance for Platinum Drug Sensitivity
por: Möltgen, Sophie, et al.
Publicado: (2020)

Platinum
Publicado: (1860)

Platinum sensitivity and non-cross-resistance of cisplatin analogue with cisplatin in recurrent cervical cancer
por: Takekuma, Munetaka, et al.
Publicado: (2015)

Tetrachlorido(1,10-phenanthroline-κ(2) N,N′)platinum(IV) monohydrate
por: Kim, Nam-Ho, et al.
Publicado: (2009)

Epigenetic priming enhances antitumor immunity in platinum-resistant ovarian cancer
por: Chen, Siqi, et al.
Publicado: (2022)

Cytotoxic sub-nanometer aqueous platinum clusters as potential antitumoral agents
por: Greco, Rossella, et al.
Publicado: (2022)

Editorial: The role of platinum-based antitumor prodrugs in medicinal inorganic chemistry
por: Margiotta, Nicola, et al.
Publicado: (2023)

Epirubicin, Cisplatin, and Capecitabine for Primary Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer: Results of a Retrospective, Single-Institution Study
por: Sayal, Karen, et al.
Publicado: (2015)

Identification of Cisplatin-Binding Proteins Using Agarose Conjugates of Platinum Compounds
por: Karasawa, Takatoshi, et al.
Publicado: (2013)

Phenethylisothiocyanate Potentiates Platinum Therapy by Reversing Cisplatin Resistance in Cervical Cancer
por: Mahapatra, Elizabeth, et al.
Publicado: (2022)

Erratum: Thermal Expansion of Platinum and Platinum-Rhodium Alloys
por: Edsinger, RE, et al.
Publicado: (2014)

Significance of platinum distribution to predict platinum resistance in ovarian cancer after platinum treatment in neoadjuvant chemotherapy
por: Uno, Kaname, et al.
Publicado: (2022)

Platinum Amalgam
por: Chase,
Publicado: (1872)

About Platinum
Publicado: (1890)

The Shortage of Platinum
Publicado: (1916)

Bis(2,2′-bipyridine-κ(2) N,N′)dichloridoplatinum(IV) dichloride monohydrate
por: Kim, Nam-Ho, et al.
Publicado: (2009)

Platinum-Based Nanoformulations for Glioblastoma Treatment: The Resurgence of Platinum Drugs?
por: Alfonso-Triguero, Paula, et al.
Publicado: (2023)

Guanidine platinum(II) complexes: synthesis, in vitro antitumor activity, and DNA interactions()
por: Legin, Anton A., et al.
Publicado: (2014)

Factors affecting platinum concentrations in human surgical tumour specimens after cisplatin.
por: Stewart, D. J., et al.
Publicado: (1995)

Structural damage of chicken red blood cells exposed to platinum nanoparticles and cisplatin
por: Kutwin, Marta, et al.
Publicado: (2014)

Semen and serum platinum levels in cisplatin‐treated survivors of germ cell cancer
por: Malone, Eoghan R., et al.
Publicado: (2021)

Toll‐like receptor 4 is activated by platinum and contributes to cisplatin‐induced ototoxicity
por: Babolmorad, Ghazal, et al.
Publicado: (2021)

Phase II trial of cisplatin, gemcitabine and pembrolizumab for platinum-resistant ovarian cancer
por: Walsh, Christine S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rt31q2f2mlnjaoescpm5jc03t7